| Multiple Sclerosis |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.99 |
| Transplantation |
0 |
0.98 |
| Disability |
0 |
0.66 |
| Biologic Therapy |
0 |
0.61 |
| Cell Transplantation |
0 |
0.97 |
| Transplant Evaluation |
0 |
0.58 |
| Disease-Modifying Therapy |
0 |
0.13 |
| Glatiramer Acetate |
0 |
0.07 |
| Multiple Sclerosis Treatment |
0 |
0.07 |
| Secondary Progressive Multiple Sclerosis |
0 |
0.07 |